RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Avalo Therapeutics Stock

Avalo Therapeutics Liabilities 2025

Avalo Therapeutics Liabilities

13.69 M USD

Ticker

AVTX

ISIN

US05338F3064

In 2025, Avalo Therapeutics's total liabilities amounted to 13.69 M USD, a -69.09% difference from the 44.28 M USD total liabilities in the previous year.

Avalo Therapeutics Aktienanalyse

What does Avalo Therapeutics do?

Avalo Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Avalo Therapeutics's Liabilities

Avalo Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Avalo Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Avalo Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Avalo Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Avalo Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Avalo Therapeutics stock

What is the level of liabilities of Avalo Therapeutics this year?

Avalo Therapeutics has a debt balance of 13.69 M USD this year.

What were the liabilities of Avalo Therapeutics compared to the previous year?

The liabilities of Avalo Therapeutics have increased by -69.09% dropped compared to the previous year.

What are the consequences of high debt for investors of Avalo Therapeutics?

High liabilities can pose a risk for investors of Avalo Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Avalo Therapeutics?

Low liabilities mean that Avalo Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Avalo Therapeutics affect the company?

An increase in liabilities of Avalo Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Avalo Therapeutics affect the company?

A decrease in the liabilities of Avalo Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Avalo Therapeutics?

Some factors that can influence the liabilities of Avalo Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Avalo Therapeutics so important for investors?

The liabilities of Avalo Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Avalo Therapeutics take to modify the liabilities?

To change its liabilities, Avalo Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Avalo Therapeutics pay?

Over the past 12 months, Avalo Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avalo Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Avalo Therapeutics?

The current dividend yield of Avalo Therapeutics is .

When does Avalo Therapeutics pay dividends?

Avalo Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avalo Therapeutics?

Avalo Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Avalo Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avalo Therapeutics located?

Avalo Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avalo Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avalo Therapeutics from 1/18/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/18/2025.

When did Avalo Therapeutics pay the last dividend?

The last dividend was paid out on 1/18/2025.

What was the dividend of Avalo Therapeutics in the year 2024?

In the year 2024, Avalo Therapeutics distributed 0 USD as dividends.

In which currency does Avalo Therapeutics pay out the dividend?

The dividends of Avalo Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Avalo Therapeutics

Our stock analysis for Avalo Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avalo Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.